Dan Lemaitre

Dan Lemaitre has an extensive and diverse work experience. Dan served as the Chairman and CEO of BlueWind Medical since September 2018. Prior to that, they were CEO of Direct Flow Medical from May 2016 to January 2017. From May 2012 to February 2016, they served as Chairman of Bioventus. Dan was also the President and CEO of White Pine Medical, leading an investor syndicate that acquired Bioventus in May 2012. Dan was the CEO of CoreValve from April 2008 to April 2009. Dan held the position of Senior Vice President at Medtronic from October 2005 to May 2008, responsible for strategic planning and corporate development. Earlier in their career, they were a Managing Director at Merrill Lynch and Cowen & Company, specializing in medical technology research. Throughout their career, Dan Lemaitre received numerous accolades, including being named to Institutional Investor's All American research team for 19 consecutive years.

Dan Lemaitre earned their Bachelor's degree in Economics from Bethany College. Dan subsequently pursued a Master of Business Administration (MBA) from Bowling Green State University from 1976 to 1978.